Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis - Trial NCT06298617
Access comprehensive clinical trial information for NCT06298617 through Pure Global AI's free database. This phase not specified trial is sponsored by Benha University and is currently Completed. The study focuses on Endometriosis. Target enrollment is 88 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Benha University
Timeline & Enrollment
N/A
Jan 01, 2023
Dec 25, 2023
Primary Outcome
Indices' ability to predict EM stage
Summary
Endometriosis (EMs) is one of the commonest chronic inflammatory disorder affecting women and
 is characterized by the presence and growth of endometrial-like glandular epithelial and
 stromal cells outside the uterus leading to multiple clinical symptoms affecting patients
 quality of life and fertility with high recurrence rate . The systemic immune inflammatory
 index (SII) and systemic inflammatory response index (SIRI) are documented as prognostic
 serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies
 for various cancers .
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06298617
Non-Device Trial